Award-winning agency Porterhouse Medical Group joins imc group with Waterland Private Equity’s support
August 6, 2020 | Digital, Insights research, Medical Communications, Porterhouse Medical Group, Publication Planning, healthcare communications, integrated medhealth communication group
Porterhouse Medical Group, specialists in medical communications and insights research, is joining imc group with the support of Waterland Private Equity. Porterhouse’s award-winning team will further imc’s ambition to become the leading, independent provider of global strategic healthcare communications and consulting services to the pharmaceutical and biotech industries.
The collaborative fusion between Porterhouse Medical Group and imc group of scientific expertise, entrepreneurial spirit and a proven track record of excellence will shape the future narrative in global healthcare communications.
Porterhouse offers strategic medical communications, publication planning and insights research. Sharing imc’s philosophy that ‘the whole is greater than the sum of its parts’ the Company is a key addition to imc’s fast-growing network of international offices and teams, which already serve some of the largest drug companies in the world including AstraZeneca and Takeda. Combining teams will strengthen the companies’ capabilities on both sides of the Atlantic.
“We’re excited to be building the future of strategic healthcare communications as we join forces with imc group, together extending our reach and service provision across North America and Europe. We’re confident that Porterhouse and imc together will continue to deliver innovative solutions for our clients during their most challenging period yet” commented Jon Hallows, Co-Founder and Joint MD, Porterhouse Medical Group.
Shairose Ebrahim, imc group Co-Founder, President & CEO commented “We’re delighted to be welcoming Porterhouse to the imc family. Combined, we will have over 165 employees across four countries, offering seamless solutions for all our clients. Together we can build on the fantastic capabilities that imc and Porterhouse collectively have, I couldn’t be more thrilled.”
Company enquiries
– imc group, Shairose Ebrahim, shairose@imcmedcom.com
– Porterhouse Medical Group, Jon Hallows, jon.hallows@porterhousemedical.com
Press enquiries
– James Isola, Maitland, jisola@maitland.co.uk +44 (0) 7841982020
– Alasdair Lennon, Maitland, alennon@maitland.co.uk +44 (0) 7342 704 229
About imc group
imc is a healthcare communications and consulting agency headquartered in London, offering deep expertise to global pharmaceutical companies across a broad range of therapy areas. Founded in 2006 by President & CEO, Shairose Ebrahim and Dr Zaileen Ebrahim, imc currently employs 100 people based largely in the UK and Canada, with further offices recently opened in USA, East of England and Egypt.
More information: www.imcmedcom.com
About Porterhouse Medical Group
Porterhouse Medical Group is a global, insight-led strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals and patients. The group was established in 2002 by Jon Hallows and Brian Parsons, employs 65 people, and is headquartered in the UK with offices in the USA.
More information: www.porterhousemedical.com
This content was provided by Porterhouse Medical Group